Skip to main content
    V

    Volitionrx Ltd (VNRX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $0.19
    -0.04 (-15.26%)

    Market Cap: $8.30M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Volitionrx Ltd (VNRX) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Volitionrx (VNRX) to earn -$2.00 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.72M. Of 5 analysts, 4 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.00, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 80% of the ratings.

    RatingAnalystsShare
    Strong Buy120.0%
    Buy360.0%
    Hold120.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    5

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 240.8%.

    Fiscal year ending Dec 31, 2026
    -$2.00
    EPS consensus, revenue $2.72M
    Fiscal year ending Dec 31, 2027
    -$0.85
    EPS consensus, revenue $9.27M
    Next report
    Mar 29, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$2.00-$2.00 to -$2.001$2.72M$2.33M to $3.50M5
    Dec 31, 2027-$0.85-$0.85 to -$0.851$9.27M$3.50M to $21.30M4

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.29-$0.37 to -$0.207$696150$470400 to $9975007

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$2.60.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$2.00-$2.62-$2.62-$2.62-$2.60N/A
    Fiscal year ending Dec 31, 2027-$0.85-$1.15-$1.15-$1.15$10.80N/A

    Frequently Asked Questions About VNRX

    What is the VNRX stock forecast?

    Consensus analyst estimates put Volitionrx's EPS at -$2.00 for the fiscal year ending Dec 31, 2026, on revenue of $2.72M. The consensus rating from 5 analysts is Buy.

    How do analysts rate VNRX stock?

    Of 5 analysts covering Volitionrx, 1 rates it Strong Buy, 3 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from VNRX next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$2.00, with estimates from -$2.00 to -$2.00 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.85, with estimates from -$0.85 to -$0.85 from 1 analyst.

    What revenue do analysts expect from Volitionrx next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.72M, with estimates from $2.33M to $3.50M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $9.27M, with estimates from $3.50M to $21.30M.

    How many analysts cover VNRX?

    5 analysts rate Volitionrx stock, and 1 analyst estimates its EPS for the fiscal year ending Dec 31, 2026.